Drug
Nivolumab Plinabulin
Nivolumab Plinabulin: highest development phase Phase 1, developed by BeyondSpring. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BeyondSpring
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nivolumab + Plinabulin NCT02812667 | Phase 1 | Non-small Cell Lung Cancer Metastatic |
Latest
No recent events.
Follow Nivolumab Plinabulin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.